mBC blog

book

Interested in articles and updates about metastatic breast cancer?

Click here to read the mBC blog!
Live for the moments that haven't happend yet

In a clinical study of more than 750 women, HALAVEN® was compared with other chemotherapies or hormone therapies commonly used to treat metastatic breast cancer (mBC). Although some women lived longer and some women did not live as long, women who were treated with HALAVEN lived, on average, 25% longer (13.2 months vs 10.6 months, respectively) than those who received another chemotherapy or hormone treatment.

LEARN ABOUT HALAVEN®

A treatment option for certain patients with metastatic breast cancer (mBC)

*The HALAVEN $0 Co-Pay Program assists eligible patients with the out-of-pocket costs of HALAVEN (up to $18,000 per year). Restrictions apply. Visit www.eisaireimbursement.com/patient/halaven/financial-assistance to see the full terms and conditions and eligibility requirements, to learn more about the program, and to download an enrollment form. Eligible commercially insured patients may pay as little as $0 per month, with an annual limit of $18,000.

mbc-blog-img-mob
blog-book

mBC blog

The Doctor Will See You Now: Making the Most of Your Next Virtual Visit

divider

Telehealth is here to stay. Here's what you need to know to make the most of your next virtual doctor's appointment. Read More

Over 80,000 patients in the US have been prescribed HALAVEN for mBC

Learn why

Halaven website prescribed icon mobile

Eligible patients may pay as little as $0*

If you need assistance paying for your medication, we may be able to help.

*The HALAVEN $0 Co-Pay Program assists eligible patients with the out-of-pocket costs of HALAVEN (up to $18,000 per year). Restrictions apply. Visit www.eisaireimbursement.com/patient/halaven/financial-assistance to see the full terms and conditions and eligibility requirements, to learn more about the program, and to download an enrollment form. Eligible commercially insured patients may pay as little as $0 per month, with an annual limit of $18,000.